Although the role of Elp3 in both tumor initiation and progression of epithelial cancers, as well as in the resistance to targeted therapy in melanoma, is well established, its role in the immune response remains poorly studied (Ladang et al, 2015; Delaunay et al, 2016; Rapino et al, 2018). Here, ELP3 is linked to melanoma.